Aging Overview

Aging gene

Gene name: MIR22
Aging type: Accelerate
Aging characteristic:
Tissue type: --
Cell name: MRC-5,Fibroblast
Gene ID: 407004
Category: ncRNA
Phenotype: Breast cancer
Experimental category: HL
PMID: 21502362
Experiment: qRT-PCR//Western blot//DAPI staining//BrdU assay//Cell proliferation assay//Flow cytometry
Description: Quantitative (q) RT-PCR analysis confirmed that miR-22 expression was increased in senescent TIG-3 and other fibroblasts and even up-regulated by more than fivefold in senescent MRC-5 cells.miR-22 also increased SA-β-gal activity miR-22 overexpression induced cell cycle arrest at G1 phase, accompanied by the decrease in percentages of S phase. The inhibitory effect of miR-22 on cell cycle progression has also been recently reported in other cancer cells.


Regulatory relationship

Target gene: SIRT1//SP1//CDK6
Official symbol(s): SIRT1//SP1//CDK6
R-AG-Target gene: --// --// --
Subcategory: Unclear
Target gene experiment: MiRanda,TargetScan,and PicTar//Luciferase reporter assay//Western blot//SA-β-gal activity assay
Target gene description: The mRNAs of SIRT1 and Sp1 contain putative binding sites for miR-22 in their 3-UTRs, and each site is broadly conservative among mammals. CDK6 mRNA contains three miR-22 binding sites in the 3'-UTR, whereas it is different in conservation for each site.In SiHa and MDA-D3 cells, miR-22 significantly reduced the luciferase activities of the full-length 3'-UTR or WT SIRT1, SP1, and CDK6 site 1 and site 3) reporters, compared with the negative cont miR. Western blot analysis showed that overexpression of miR-22 markedly down-regulated SIRT1, SP1, and CDK6 in SiHa and MDA-D3 cells.We forced SiHa or MDA-D3 cells to express SIRT1, Sp1, or CDK6 using plasmid constructs lacking 3-UTRs of these genes. Indeed, miR-22–induced cell growth repression and SA-β-gal activity were partially rescued by the introduction of SIRT1, CDK6, or Sp1 in either SiHa cells or MDA-D3 cells (not depicted), although it seemed weak for the effect of Sp1 overexpression on cell growth, which might be because of the indirect role of Sp1 in the pRb pathway of senescence.

Regulatory pathway: --
R-AG-Pathway: --
Pathway experiment: --
Pathway description: --


Aging network

Annotation:

The green line represents Upregulation.

The purple line represents Downregulation.

The orange line represents Activation.

The yellow line represents Inhibition.

The gray line represents Unclear.



About risk SNP and eQTL

Loading,please wait...